BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5444685)

  • 1. [The use of pyrimidine nucleosides (cytidine and uridine) in the therapy of cerebrl vascular disorders].
    Ferrari G
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Feb; 94(1):207-16. PubMed ID: 5444685
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of certain nonvasoactive nucleosides (cytidine and uridine) in the treatment of cerebrovascular diseases.
    Sanguineti I; Zerbi D
    Panminerva Med; 1968 Mar; 10(3):81-92. PubMed ID: 5650178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of some non vasoactive nucleosides (cytidine and uridine) in therapy of cerebral vascular diseases].
    Sanguineti I; Zerbi D
    Minerva Med; 1965 Oct; 56(79):3352-61. PubMed ID: 5846622
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapeutic use of the nucleosides, cytidine and uridine, in some neurological diseases].
    Monticone GF; Bergamasco B; Cognazzo A
    Minerva Med; 1966 Dec; 57(101):4348-52. PubMed ID: 5958226
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with proxazole in the therapy of cerebrovascular diseases].
    Mainieri L
    Minerva Med; 1974 May; 65(40):2281-6. PubMed ID: 4422429
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of cytidine and uridine in the treatment of neuropsychological syndromes caused by brain diseases of various origins].
    Jann G; Delzanno GB
    Minerva Med; 1969 May; 60(42):2092-108. PubMed ID: 5815372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
    Blanc A; Perset P
    Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytidine and uridine nucleosides in vascular encephalopathies (preliminary report)].
    Cervantes León G; González-González J; Padilla Nibra J
    Neurol Neurocir Psiquiatr; 1970; 11(1):11-8. PubMed ID: 5527965
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia?
    Fornai F; Busceti CL; Ferrucci M; Lazzeri G; Ruggieri S
    Funct Neurol; 2002; 17(2):93-9. PubMed ID: 12224797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of cytidine and uridine on dysproteinemia in the nephrotic syndrome].
    Gabriele C; Cimaglia A
    Riv Anat Patol Oncol; 1967 Mar; 31(3):Suppl:28-30. PubMed ID: 5603973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of short-term administration of cytidine, uridine and levoglutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease.
    Manna V; Martucci N
    Int J Clin Pharmacol Res; 1988; 8(3):199-210. PubMed ID: 3403106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases].
    Montanini R; Gaspari G
    Minerva Cardioangiol; 1969 Dec; 17(12):1096-102. PubMed ID: 5373481
    [No Abstract]   [Full Text] [Related]  

  • 18. Devincan therapy of cerebrovascular senescence.
    Földi M; Tényi M; Wagner A; Börcsök E
    Ther Hung; 1968; 16(4):163-4. PubMed ID: 5719144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nucleosides in high doses in the course of radiotherapy].
    Gavioli G
    Minerva Ortop; 1971 Nov; 22(11):405-14. PubMed ID: 5135681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.